Physician profile
Daniel Warren Smith
NPI 1043653942
$1,041.09
in general payments reported to CMS, 2019-2025
13 companies · $90.25 in 2025
The $90.25 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.22 · 2023: $370 · 2024: $550 · 2025: $90.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744 · Travel and Lodging: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.73 |
| Travel and Lodging | $266.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $266.14 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $250.81 | 2023-2024 | Bard Urinary Drainage Bag |
| Urogen Pharma, INC. | $169.08 | 2023-2024 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $72.45 | 2023-2024 | Pylarify |
| Olympus America INC. | $59.28 | 2023 | Itind System |
| Laborie Medical Technologies Corp. | $53.32 | 2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Procept Biorobotics Corporation | $34.20 | 2024 | Aquabeam System |
| Urovant Sciences INC | $31.22 | 2021 | |
| 180 Medical, INC. | $27.95 | 2023 | |
| Myriad Genetic Laboratories, INC. | $24.28 | 2024 | Prolaris |
| Accord Healthcare, INC. | $23.24 | 2025 | |
| Immunitybio, INC. | $15.43 | 2024 | |
| Telix Pharmaceuticals | $13.69 | 2025 | Illuccix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.